ClinicalTrials.Veeva

Menu

Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers (PSYCHOCOKE)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Cocaine-induced Psychotic Disorder During Intoxication

Treatments

Other: Hair sample
Other: Interviews
Other: Blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT01569347
2011-A00115-36 (Other Identifier)
NI10027 / AOM 10165

Details and patient eligibility

About

The aim of this study is to determine the clinical, genetic and environmental factors associated with the phenotype "severe psychotic symptoms" caused by cocaine.

Full description

The second purpose is to include gene x environment interaction and to analyse the factors associated with the presence or the absence of severe psychotic symptoms induced by cocaine.

Enrollment

417 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults, cocaine users, who have signed an informed consent

Exclusion criteria

  • Poor venous condition (for blood samples), specially protected people, non French speaking, people who refuse to sign the consent.

Trial design

417 participants in 1 patient group

1: Cocaine users
Description:
Adults, cocaine users
Treatment:
Other: Blood sample
Other: Hair sample
Other: Interviews

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems